Skip to main content
SpringerLink
Log in

Breast Cancer and Renal Cell Cancer Metastases to the Brain

  • Chapter
  • First Online:
Tumors of the Central Nervous system, Volume 3

Part of the book series: Tumors of the Central Nervous System ((TCNS,volume 3))

  • 1660 Accesses

Abstract

Metastatic tumors from systemic cancers comprise the majority of brain tumors. These tumors most commonly originate from the lung and breast skin or kidney cancers. There are numerous similarities regarding the pathophysiology of these entities. Primary tumors spread to the central nervous system in a stepwise and highly concerted fashion. Tumor particles must breach the containment organ and subsequently travel via the blood stream to lodge within the brain. Trans-endothelial migration allows cells to penetrate the blood brain barrier. Tumor emboli must then survive and grow within the brain microenvironment with local nutrient supply and glial support. Breast and renal tumors utilize an array of similar molecular signals to accomplish these tasks: such as the Ras/MEK/MAPK and PI-3 K/Akt pathways. This may explain why these primaries have a preponderance to metastasize to the brain. As antioncogenic therapies become more effective and patients with systemic cancers are afforded longer survival, cerebral invasion becomes more common and more important to overall management. Based on recent scientific data, emerging therapeutic targets for brain metastasis include vascular endothelial growth factor (VEGF), the epidermal growth factor receptor (EGFR) family, chemokines and mTOR.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ali S, Lazennec G (2007) Chemokines: novel targets for breast cancer metastasis. Canc Metastasis Rev 26:401–420

    Article  CAS  Google Scholar 

  • Altundag K, Bondy ML, Mirza NQ, Kau SW, Broglio K, Hortobagyi GN, Rivera E (2007) Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer 110:2640–2647

    Article  PubMed  CAS  Google Scholar 

  • Balkwill F (2004) Cancer and the chemokine network. Nat Rev Canc 4:540–550

    Article  CAS  Google Scholar 

  • Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22:2865–2872

    Article  PubMed  Google Scholar 

  • Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM (2003) Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer 97:545–553

    Article  PubMed  Google Scholar 

  • Cheng X,, Hung MC (2007) Breast cancer brain metastases. Cancer Metastasis Rev 26:635–643

    Article  PubMed  Google Scholar 

  • Eichler AF, Kuter I, Ryan P, Schapira L, Younger J, Henson JW (2008) Survival in patients with brain metastases from breast cancer: the importance of HER-2 status. Cancer 112:2359–2367

    Article  PubMed  CAS  Google Scholar 

  • Eichler AF, Plotkin SR (2008) Brain metastases. Curr Treat Options Neurol 10:308–314

    Article  PubMed  Google Scholar 

  • Engelhardt B, Sorokin L (2009) The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol 31:497–511

    Article  PubMed  Google Scholar 

  • Evans AJ, James JJ, Cornford EJ, Chan SY, Burrell HC, Pinder SE, Gutteridge E, Robertson JF, Hornbuckle J, Cheung KL (2004) Brain metastases from breast cancer: identification of a high-risk group. Clin Oncol (R Coll Radiol) 16:345–349

    CAS  Google Scholar 

  • Fitzgerald DP, Palmieri D, Hua E, Hargrave E, Herring JM, Qian Y, Vega-Valle E, Weil RJ, Stark AM, Vortmeyer AO, Steeg PS (2008) Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization. Clin Exp Metastasis 25:799–810

    Article  PubMed  Google Scholar 

  • Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31

    Article  PubMed  CAS  Google Scholar 

  • Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75:5–14

    Article  PubMed  Google Scholar 

  • Grandinetti CA, Goldspiel BR (2007) Sorafenib and sunitinib: novel targeted therapies for renal cell cancer. Pharmacotherapy 27:1125–1144

    Article  PubMed  CAS  Google Scholar 

  • Grossi PM, Ochiai H, Archer GE, McLendon RE, Zalutsky MR, Friedman AH, Friedman HS, Bigner DD, Sampson JH (2003) Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer. Clin Cancer Res 9:5514–5520

    PubMed  CAS  Google Scholar 

  • Hakyemez B, Erdogan C, Gokalp G, Dusak A, Parlak M (2010) Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI. Clin Radiol 65:15–20

    Article  PubMed  CAS  Google Scholar 

  • Heldwein FL, Escudier B, Smyth G, Souto CA, Vallancien G (2009) Metastatic renal cell carcinoma management. Int Braz J Urol 35:256–270

    Article  PubMed  Google Scholar 

  • Hicks DG, Short SM, Prescott NL, Tarr SM, Coleman KA, Yoder BJ, Crowe JP, Choueiri TK, Dawson AE, Budd GT, et al (2006) Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR. Am J Surg Pathol 30:1097–1104

    PubMed  Google Scholar 

  • Hill KL Jr., Lipson AC, Sheehan JM (2009) Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma. J Neurosurg 111:497–503

    Article  PubMed  Google Scholar 

  • Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, et al (2007) Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356:2271–2281

    Article  PubMed  CAS  Google Scholar 

  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96

    Article  PubMed  Google Scholar 

  • Kapoor A (2009) Inhibition of mTOR in kidney cancer. Curr Oncol 16(Suppl 1):S33–S39

    PubMed  Google Scholar 

  • Kato T, Kameoka S, Kimura T, Nishikawa T, Kobayashi M (2003) The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. Br J Cancer 88:1900–1908

    Article  PubMed  CAS  Google Scholar 

  • Lai R, Dang CT, Malkin MG, Abrey LE (2004) The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma. Cancer 101:810–816

    Article  PubMed  CAS  Google Scholar 

  • Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715–721

    Article  PubMed  Google Scholar 

  • Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB, Kim WK (2008) Brain metastases in breast cancer: prognostic factors and management. Breast Cancer Res Treat 111:523–530

    Article  PubMed  Google Scholar 

  • Lin NU, Bellon JR, Winer EP (2004) CNS metastases in breast cancer. J Clin Oncol 22:3608–3617

    Article  PubMed  Google Scholar 

  • Lin NU, Carey LA, Liu MC, Younger J, Come SE, Ewend M, Harris GJ, Bullitt E, Van den Abbeele AD, Henson JW et al (2008) Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol 26:1993–1999

    Article  PubMed  CAS  Google Scholar 

  • Lin NU, Dieras V, Paul D, Lossignol D, Christodoulou C, Stemmler HJ, Roche H, Liu MC, Greil R, Ciruelos E et al. (2009) Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clin Cancer Res 15:1452–1459

    Article  PubMed  CAS  Google Scholar 

  • Meric-Bernstam F, Hung MC (2006) Advances in targeting human epidermal growth factor receptor-2 signaling for cancer therapy. Clin Canc Res 12:6326–6330

    Article  CAS  Google Scholar 

  • Miles FL, Pruitt FL, van Golen KL, Cooper CR (2008) Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis 25:305–324

    Article  PubMed  CAS  Google Scholar 

  • Miller KD, Weathers T, Haney LG, Timmerman R, Dickler M, Shen J, Sledge GW Jr. (2003) Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival. Ann Oncol 14:1072–1077

    Article  PubMed  CAS  Google Scholar 

  • Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Grunwald V, Thompson JA, Figlin RA, Hollaender N, Urbanowitz G, Berg WJ, Kay A, Lebwohl D, Ravaud A (2008) Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 372:449–456

    Article  PubMed  CAS  Google Scholar 

  • Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56

    Article  PubMed  CAS  Google Scholar 

  • Nussbaum RR, Werner U, Pichlmayr R (1996) Liver metastases in breast carcinoma. Results of partial liver resection. Chirurg 67(3):234–247

    Google Scholar 

  • Ouban A, Ahmed AA (2010) Claudins in human cancer: a review. Histol Histopathol 25:83–90

    PubMed  CAS  Google Scholar 

  • Palmieri D, Chambers AF, Felding-Habermann B, Huang S, Steeg PS (2007) The biology of metastasis to a sanctuary site. Clin Cancer Res 13:1656–1662

    Article  PubMed  CAS  Google Scholar 

  • Palmieri D, Smith QR, Lockman PR, Bronder J, Gril B, Chambers AF, Weil RJ, Steeg PS (2006) Brain metastases of breast cancer. Breast Dis 26:139–147

    PubMed  CAS  Google Scholar 

  • Patanaphan V, Salazar OM, Risco R (1988) Breast cancer: metastatic patterns and their prognosis. South Med J 81:1109–1112

    Article  PubMed  CAS  Google Scholar 

  • Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, Crivellari D, Fey MF, Murray E, Pagani O, Simoncini E, Castiglione-Gertsch M, Gelber RD, Coates AS, Goldhirsch A (2006) Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 17:935–944

    Article  PubMed  CAS  Google Scholar 

  • Ranasinghe MG, Sheehan JM (2007) Surgical management of brain metastases. Neurosurg Focus 22:E2

    Article  PubMed  Google Scholar 

  • Ravaud A, Hawkins R, Gardner JP, von der Maase H, Zantl N, Harper P, Rolland F, Audhuy B, Machiels JP, Petavy F, Gore M, Schoffski P, El-Hariry I (2008) Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial. J Clin Oncol 26:2285–2291

    Article  PubMed  CAS  Google Scholar 

  • Reckamp KL, Strieter RM, Figlin RA (2008) Chemokines as therapeutic targets in renal cell carcinoma. Expert Rev Anticancer Ther 8:887–893

    Article  PubMed  CAS  Google Scholar 

  • Sawaya R (2004) Chairman’s reflection on the past, present and future of neurosurgical oncology. J Neuro-Oncol 69: 19–23

    Article  Google Scholar 

  • Schouten LJ, Rutten J, Huveneers HA, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94(10):2698–2705

    Article  PubMed  Google Scholar 

  • Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD (2003) Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 98:342–349

    Article  PubMed  Google Scholar 

  • Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, Kabbinavar FF, Pantuck AJ, Belldegrun AS (2008) Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer 113:1641–1648

    Article  PubMed  Google Scholar 

  • Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783–792

    Article  PubMed  CAS  Google Scholar 

  • Stemmler HJ, Heinemann V (2008) Central nervous system metastases in HER-2-overexpressing metastatic breast cancer: a treatment challenge. Oncologist 13:739–750

    Article  PubMed  Google Scholar 

  • Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R (2006) Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 107: 696–704

    Article  PubMed  Google Scholar 

  • Tsukada Y, Fouad A, Pickren JW, Lane WW (1983) Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 52:2349–2354

    Article  PubMed  CAS  Google Scholar 

  • Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167:913–920

    Article  PubMed  CAS  Google Scholar 

  • Zimm S, Wampler GL, Stablein D, Hazra T, Young HF (1981) Intracerebral metastases in solid-tumor patients: Natural history and results of treatment. Cancer 48(2):384–394

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, PA, 17033-0850, USA

    Jonas M. Sheehan & Akshal S. Patel

Authors
  1. Jonas M. Sheehan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akshal S. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonas M. Sheehan .

Editor information

Editors and Affiliations

  1. , Kean University, Department of Biological Sciences, Morris Avenue 1000, UNION, 07083, New Jersey, USA

    M.A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Sheehan, J.M., Patel, A.S. (2011). Breast Cancer and Renal Cell Cancer Metastases to the Brain. In: Hayat, M. (eds) Tumors of the Central Nervous system, Volume 3. Tumors of the Central Nervous System, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1399-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-1399-4_8

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-1398-7

  • Online ISBN: 978-94-007-1399-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation